Phase II trial of vinorelbine and trastuzumab in patients with HER2-positive metastatic breast cancer. A prospective, open label, non-controlled, multicenter phase II trial (to investigate efficacy and safety of this combination chemotherapy).

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples